Jan Kronke
Albert Einstein Allee 23
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Journal: Nature medicine
Published: July 06, 2026
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).
Journal: Annals of hematology
Published: April 16, 2026
Teclistamab induces rapid clinical response and deep tissue depletion in refractory systemic sclerosis-a case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
Teclistamab for treatment-refractory autoimmune diseases: a multicentre case series.
Journal: Annals of the rheumatic diseases
Published: January 19, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5D.
Journal: Leukemia
Published: December 06, 2025
Malnutrition in gastrointestinal cancer manifests before systemic therapy and is associated with fatigue and reduced physical quality of life.
Journal: The oncologist
Published: November 08, 2025
Functional and molecular analyses reveal impaired HSPCs in Multiple Myeloma patients post-induction.
Functional and molecular analyses reveal impaired HSPCs in Multiple Myeloma patients post-induction.
Journal: Stem cells translational medicine
Published: August 29, 2025
Enhancing Solubility in VHL-Based PROTACs: Optimized USP7 Degraders for Improved Developability.
Journal: Journal of medicinal chemistry
Published: July 17, 2025
Targetable BIRC5 dependency in therapy-resistant TP53 mutated acute myeloid leukemia.
Journal: bioRxiv : the preprint server for biology
Published: June 06, 2025
Last Updated: 09/26/2026